ADAM17 and Alzheimer disease: If sTREM2 is indeed more protective against AD than full-length TREM2, then antibodies that increased sTREM2 shedding might be beneficial, or other treatments designed to activate sTREM2 shedding e.g., by activating ADAM10 and ADAM17.